Schonfeld Strategic Advisors LLC - SUPERNUS PHARMACEUTICALS INC ownership

SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 298 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is 1.94 and the average weighting 0.2%.

Quarter-by-quarter ownership
Schonfeld Strategic Advisors LLC ownership history of SUPERNUS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$1,024,445
-65.5%
37,158
-62.4%
0.01%
-69.2%
Q2 2023$2,972,572
-33.6%
98,888
-20.0%
0.03%
-39.5%
Q1 2023$4,479,223
+90.5%
123,633
+87.6%
0.04%
+115.0%
Q4 2022$2,350,831
+313.2%
65,905
+292.3%
0.02%
+300.0%
Q3 2022$569,000
-77.9%
16,800
-78.9%
0.01%
-78.3%
Q1 2022$2,579,000
+618.4%
79,801
+548.8%
0.02%
+666.7%
Q4 2021$359,000
-55.1%
12,300
-38.4%
0.00%
-95.9%
Q3 2017$799,00019,9670.07%
Other shareholders
SUPERNUS PHARMACEUTICALS INC shareholders Q4 2017
NameSharesValueWeighting ↓
ASHFORD CAPITAL MANAGEMENT INC 698,676$41,816,0005.51%
Provident Investment Management, Inc. 543,194$32,510,0004.61%
NEUMEIER POMA INVESTMENT COUNSEL LLC 426,250$25,511,0002.37%
KOPP INVESTMENT ADVISORS LLC 41,879$2,506,0002.35%
AlphaOne Investment Services, LLC 126,279$7,558,0002.17%
Ranger Investment Management 468,933$28,066,0001.96%
Bruce & Co., Inc. 158,058$9,459,0001.88%
Penserra Capital Management LLC 244,371$29,030,0001.83%
SHAKER INVESTMENTS LLC/OH 49,642$2,971,0001.83%
Bridge City Capital, LLC 47,795$2,861,0001.81%
View complete list of SUPERNUS PHARMACEUTICALS INC shareholders